CompuMed Valuation
| CMPD Stock | USD 5.19 0.22 4.43% |
At this time, the firm appears to be overvalued. CompuMed shows a prevailing Real Value of $3.91 per share. The current price of the firm is $5.19. Our model approximates the value of CompuMed from analyzing the firm fundamentals such as Return On Equity of -0.3, profit margin of (0.02) %, and Current Valuation of 4.12 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that CompuMed's price fluctuation is risky at this time. Calculation of the real value of CompuMed is based on 3 months time horizon. Increasing CompuMed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CompuMed pink sheet is determined by what a typical buyer is willing to pay for full or partial control of CompuMed. Since CompuMed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CompuMed Pink Sheet. However, CompuMed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.19 | Real 3.91 | Hype 5.19 | Naive 5.12 |
The real value of CompuMed Pink Sheet, also known as its intrinsic value, is the underlying worth of CompuMed Company, which is reflected in its stock price. It is based on CompuMed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of CompuMed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of CompuMed helps investors to forecast how CompuMed pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CompuMed more accurately as focusing exclusively on CompuMed's fundamentals will not take into account other important factors: About CompuMed Valuation
The pink sheet valuation mechanism determines CompuMed's current worth on a weekly basis. Our valuation model uses a comparative analysis of CompuMed. We calculate exposure to CompuMed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CompuMed's related companies.CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California. Compumed operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 8 people.
8 Steps to conduct CompuMed's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CompuMed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CompuMed's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CompuMed's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CompuMed's revenue streams: Identify CompuMed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CompuMed's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CompuMed's growth potential: Evaluate CompuMed's management, business model, and growth potential.
- Determine CompuMed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CompuMed's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for CompuMed Pink Sheet analysis
When running CompuMed's price analysis, check to measure CompuMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuMed is operating at the current time. Most of CompuMed's value examination focuses on studying past and present price action to predict the probability of CompuMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuMed's price. Additionally, you may evaluate how the addition of CompuMed to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |